Expert Picks From ACG 2024: Part 1

In this first installment of Expert Picks from ACG 2024, Brooks D. Cash, MD, FACG, discusses six abstracts from the ...

DECEMBER 18, 2024

Long-Acting Apraglutide Reduces Need for Parenteral Support

Apraglutide reduces the need for parenteral nutrition in people with intestinal failure due to short bowel ...

SEPTEMBER 6, 2024

Narrative Medicine Can Help Improve Care In Short Bowel Syndrome

Open dialogue between patients and caregivers is crucial when caring for patients with short bowel syndrome.

AUGUST 3, 2023

Twice-Monthly Injection of Investigational Agent Vurolenatide Could Benefit Patients With SBS

In this issue of “Just a Phase,” we look at a drug that could increase nutrient absorption in patients ...

APRIL 29, 2022

Novel Device Uses Mechanotransduction to Stimulate Tissue Growth and Treat Short Bowel Syndrome

Applying the concept of mechanotransduction to the small intestine in animal models, researchers have had success ...

FEBRUARY 28, 2022

Safety Data Reassuring for Teduglutide in Children

A pooled analysis of four clinical studies of teduglutide (Gattex, Takeda) in children with short bowel syndrome ...

FEBRUARY 19, 2020

Pediatric Intestinal Failure

The term “intestinal failure” signifies the inability of the body to meet the digestive, absorptive and ...

OCTOBER 22, 2019

Gattex Approved for Use in Children as Young as 1 Year

The FDA expanded the indication of teduglutide (Gattex, Takeda) for injection to include pediatric patients 1 year ...

MAY 24, 2019